GSK plc Logo

GSK plc (GLAXF)

OTC

Currency in USD
25.50
+0.15 (+0.59%)

Closed

Aug 21, 2026

Day's Range

24.95
25.71

52 wk Range

18.99
31.48

Overview - GLAXF - GSK plc

Key Statistics

Valuation

Enterprise Value

159.48B

P/E (Trailing)

‪15.93‬

P/E (Forward)

‪11.59‬

PEG Ratio

‪-0.22‬

Price / Sales (TTM)

‪3.07‬

Price / Book

‪4.27‬

EV / EBITDA

‪10.80‬

Profitability

Gross Margin

‪73.05%‬

Profit Margin

‪14.52%‬

Operating Margin

‪30.94%‬

Return on Assets

‪10.00%‬

Return on Equity

‪33.38%‬

Ownership

Shares Outstanding

4.00B

Float

3.88B

Held by Insiders

‪1.74%‬

Held by Institutions

‪48.18%‬

Price stats

Beta

‪0.29‬

50-Day Avg

‪25.75‬

200-Day Avg

‪25.82‬

Dividends

Payout Ratio

‪56.88%‬

Frequency

Quarterly

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 16, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - GLAXF - GSK plc

Peers - GLAXF - GSK plc

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on OTC.

Profile Summary - GLAXF - GSK plc

About

GSK plc is a global biopharma company dedicated to uniting science, technology, and talent to get ahead of disease. Its primary purpose is to positively impact the health of 2.5 billion people by the end of the decade through innovative prevention and treatment strategies. The company focuses its research and…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees68.62K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.